Avista Corp

AVA remains in a Stage 2 advancing regime with a bullish medium-term trend supported by rising EMAs and higher highs. However, recent exhaustion at marginal highs and rejection at resistance have removed a clear timing edge. Execution should be deferred and targeted on pullbacks into the rising EMAs for controlled entries.

• ↑Q1 EPS $1.11, up 13% YoY; management expects 4–6% annual growth
• ↑2026 CapEx of $615M and $3.4B planned through 2030 drives 8% rate-base growth
• ↓Ongoing Washington rate case uncertainties may delay interim rate relief